Atnahs Pharma Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ATNAHS PHARMA US, and what generic and branded alternatives to ATNAHS PHARMA US drugs are available?
ATNAHS PHARMA US has five approved drugs.
Summary for Atnahs Pharma Us
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 3 |
| NDAs: | 5 |
Drugs and US Patents for Atnahs Pharma Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-004 | Apr 15, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Atnahs Pharma Us | KETOROLAC TROMETHAMINE | ketorolac tromethamine | TABLET;ORAL | 216407-001 | Oct 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Atnahs Pharma Us | EC-NAPROSYN | naproxen | TABLET, DELAYED RELEASE;ORAL | 020067-002 | Oct 14, 1994 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Atnahs Pharma Us | EC-NAPROSYN | naproxen | TABLET, DELAYED RELEASE;ORAL | 020067-003 | Oct 14, 1994 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Atnahs Pharma Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-003 | Approved Prior to Jan 1, 1982 | 3,998,966 | ⤷ Sign Up |
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-002 | Approved Prior to Jan 1, 1982 | 4,001,301 | ⤷ Sign Up |
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-002 | Approved Prior to Jan 1, 1982 | 3,998,966 | ⤷ Sign Up |
| Atnahs Pharma Us | NAPROSYN | naproxen | SUSPENSION;ORAL | 018965-001 | Mar 23, 1987 | 3,904,682 | ⤷ Sign Up |
| Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-004 | Apr 15, 1982 | 3,998,966 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
